Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer

Breast Cancer Research and Treatment

Volumn 65, Issue 2, 2001, Pages 119-124

  Milla Santos, A ^a   Milla, L ^a   Rallo, L ^a   Solano, V ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Advanced breast cancer; Positive hormonal receptors; Postmenopausal; Randomized trial; Tamoxifen; Toremifene

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN; TOREMIFENE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HORMONE DEPENDENCE; HOT FLUSH; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; NAUSEA; PHASE 3 CLINICAL TRIAL; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; TREATMENT OUTCOME; VOMITING;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, HORMONE-DEPENDENT; POSTMENOPAUSE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TAMOXIFEN; TOREMIFENE;

EID: 0035127464     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006440802709     Document Type: Article

References (31)

1. Use of tamoxifen for breast cancer: Twenty-eight years later
2. Hormone replacement therapy in women with a history of breast carcinoma
3. Growth regulation by nuclear hormone receptors
4. Frequent and specific mutations of the rat P53 gene in hepatocarcinomas induced by tamoxifen
5. Endometrial cancer in tamoxifen treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
6. Adjuvant tamoxifen therapy and second primary malignancies
7. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen
8. Tamoxifen and toremifene in breast cancer: Comparison of safety and efficacy
9. Apoptosis in toremifene-Induced growth inhibition of human breast cancer cells in vivo and in vitro
10. Toremifene: A review of its pharmacological properties and clinical efficacy in the management of advanted breast cancer
11. Reporting results of cancer treatments
12. Toxicity and response criteria of Eastern Cooperative Oncology Group
13. An analysis of variance test for normality
14. Nonparametric estimation from incomplete observations
15. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and Design
16. Should clinicians be concerned about the carcinogenic potential of tamoxifen?
17. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients
18. Second cancers after adjuvant tamoxifen therapy for breast cancer
19. Tamoxifen and secondary tumours: An update
20. Genotoxicity studies with the antiestrogen toremifene
21. Randomized comparison of Tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer
22. A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer
23. Comparison of Toremifene and Tamoxifen in postmenopausal patients with advanced breast cancer: A randomized double-blind, the nordic phase III study